Metabolomics to discriminate between acute decompensation and acute-on-chronic liver failure in cirrhosis

J Hepatol. 2020 Sep;73(3):730-732. doi: 10.1016/j.jhep.2020.03.021. Epub 2020 Jul 14.

Authors

Mark J W McPhail¹, Muireann Coen²

Affiliations

¹ Liver Intensive Therapy Unit, Institute of Liver Studies, Department of Inflammation Biology, Kings College, London, United Kingdom. Electronic address: mark.mcphail@kcl.ac.uk.
² Department of Metabolism, Digestion and Reproduction, Imperial College, London, United Kingdom; Oncology Safety, Clinical Pharmacology & Safety Sciences, R&D, Astra Zeneca, Cambridge, United Kingdom.

PMID: 32674883
DOI: 10.1016/j.jhep.2020.03.021

No abstract available

Publication types

Letter
Comment

MeSH terms

Acute-On-Chronic Liver Failure* / diagnosis
Acute-On-Chronic Liver Failure* / etiology
Humans
Inflammation
Liver Cirrhosis / complications
Liver Cirrhosis / diagnosis
Metabolomics
Mitochondria